No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

HomeMEDICAL DEVICES, TECHNOLOGIES, EQUIPMENT, SUPPLIES

Category: MEDICAL DEVICES, TECHNOLOGIES, EQUIPMENT, SUPPLIES

Discover Reeva FT: Revolutionizing Wound...

Reeva FT is offered in a variety of sizes: 2x2 cm, 2x3 cm, 4x4 cm, 4x6 cm, 4x8 cm, and 10x15 cm. Reeva FT is confirmed by the FDA Tissue Reference Group to meet the criteria for regulation solely under Section 361 of the PHS Act as defined in 21 CFR Part 1271.

Summus Medical Laser | Launches...

The RWE Program will expand Summus Laser's Class IV Laser Therapy research to generate validated and statistically significant datasets that will be used to enhance patient care, outcomes, and to further product innovations.

Discover Reeva FT: Revolutionizing Wound Covering for Healthcare Pros

Reeva FT is offered in a variety of sizes: 2x2 cm, 2x3 cm, 4x4 cm, 4x6 cm, 4x8 cm, and 10x15 cm. Reeva FT is confirmed by the FDA Tissue Reference Group to meet the criteria for regulation solely under Section 361 of the PHS Act as defined in 21 CFR Part 1271.

A New Type of CPR Announces CPR Therapeutics Inc.

These studies, undertaken at the Halperin Cardiology Bioengineering Laboratory at the Johns Hopkins Hospital, confirmed the Company’s foundational concept that multiple CPR pump mechanisms can be combined to produce dramatic improvements in hemodynamics.

Pulmonx Announces National Reimbursement in France for Zephyr Endobronchial Valve

Pulmonx advises the Zephyr Valve procedure, done through a simple bronchoscopy with no incision or cutting, is clinically proven to improve patients’ breathing, exercise capacity, and quality of life, without the risks of major surgery.

PASCAL Transcatheter Valve Repair System Receives European Approval For Tricuspid Repair

The PASCAL system is indicated in Europe for the percutaneous reconstruction of the tricuspid valve through leaflet repair by tissue approximation.

Inari Medical Launches Initial Public Offering

Inari is offering 7,333,000 shares of its common stock. In addition, Inari expects to grant the underwriters a 30-day option to purchase up to an additional 1,099,950 shares of its common stock.

COVID-19 Patients at Higher Risk of Dangerous Blood Clots Reports Sky Medical Technology

With VTE recognized as a major contributor to COVID-19 multi-organ failure, anticoagulation is critical and drug prophylaxis is the primary intervention, especially for immobile patients on ventilators at risk of VTE in ICU. Similar increases in thrombotic risk were seen with H1N1m influenza (Swine Flu).

Nevro Announces CE Mark Approval of Senza® Omnia™ Spinal Cord Stimulation System to Treat Chronic Pain

The Nevro Omnia™ Spinal Cord Stimulation System is a completely new SCS platform and consists of a number of new components.

Ostial Corporation Reaches 15,000 FLASH™ System Units Sold

FLASH is the first and only dual balloon-based system designed for use in aorto-ostial angioplasty in coronary and peripheral cases notes Ostial Corporation.

Medical Device Maker Ambu Launches New Single-Use Cystoscope for Improved Workflow and Enhanced Productivity Benefits

The Ambu aScope™ 4 Cysto will give urologists immediate access to a single-use cystoscope that can be used for procedures such as bladder cancer surveillance, stent removal and other common cystoscopy procedures.

By using this website you agree to accept Medical Device News Magazine Privacy Policy